FOXQ1 expression activated the following pathways in prostate adenocarcinoma: the IL6/JAK/STAT3 signaling pathway, interferon–alpha response pathway, UV response pathway, apoptosis pathway, and allograft rejection pathway (Figure 7C). Here, FOXQ1 is linked to prostate adenocarcinoma.